A detailed history of Bar Harbor Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Bar Harbor Wealth Management holds 177,433 shares of PFE stock, worth $4.87 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
177,433
Previous 178,302 0.49%
Holding current value
$4.87 Million
Previous $4.99 Million 2.93%
% of portfolio
0.33%
Previous 0.34%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$27.7 - $31.39 $24,071 - $27,277
-869 Reduced 0.49%
177,433 $5.13 Million
Q2 2024

Jul 17, 2024

SELL
$25.26 - $29.6 $44,760 - $52,451
-1,772 Reduced 0.98%
178,302 $4.99 Million
Q1 2024

Apr 23, 2024

SELL
$25.89 - $29.73 $986,305 - $1.13 Million
-38,096 Reduced 17.46%
180,074 $5 Million
Q4 2023

Jan 17, 2024

SELL
$26.13 - $33.94 $569,137 - $739,247
-21,781 Reduced 9.08%
218,170 $6.28 Million
Q3 2023

Nov 28, 2023

SELL
$32.09 - $37.51 $647,736 - $757,139
-20,185 Reduced 7.76%
239,951 $7.96 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $323,490 - $374,271
8,956 Added 3.57%
260,136 $9.54 Million
Q1 2023

Apr 24, 2023

BUY
$39.39 - $51.28 $4,923 - $6,410
125 Added 0.05%
251,180 $10.2 Million
Q4 2022

Jun 09, 2023

SELL
$41.75 - $54.5 $5,218 - $6,812
-125 Reduced 0.05%
251,055 $12.9 Million
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $14,863 - $19,402
356 Added 0.14%
251,055 $12.9 Million
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $218 - $267
-5 Reduced -0.0%
250,699 $11 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $1.53 Million - $1.81 Million
32,898 Added 15.1%
250,704 $13.1 Million
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $1 Million - $1.24 Million
21,873 Added 11.16%
217,806 $11.3 Million
Q4 2021

Jan 28, 2022

SELL
$41.32 - $61.25 $72,103 - $106,881
-1,745 Reduced 0.88%
195,933 $11.6 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $11,147 - $14,319
284 Added 0.14%
197,678 $8.5 Million
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $77,278 - $87,543
-2,152 Reduced 1.08%
197,394 $7.73 Million
Q1 2021

May 06, 2021

SELL
$33.49 - $37.77 $144,174 - $162,599
-4,305 Reduced 2.11%
199,546 $7.23 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $12,183 - $15,491
364 Added 0.18%
203,851 $7.5 Million
Q3 2020

Nov 02, 2020

SELL
$31.75 - $37.25 $245,681 - $288,240
-7,738 Reduced 3.66%
203,487 $7.47 Million
Q2 2020

Aug 04, 2020

SELL
$30.12 - $36.54 $547,099 - $663,712
-18,164 Reduced 7.92%
211,225 $6.91 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $1.03 Million - $1.47 Million
-38,076 Reduced 14.24%
229,389 $7.49 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $516,712 - $586,402
-15,696 Reduced 5.54%
267,465 $10.5 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $232,043 - $300,892
7,142 Added 2.59%
283,161 $10.2 Million
Q2 2019

Aug 01, 2019

BUY
$36.98 - $41.52 $773,399 - $868,349
20,914 Added 8.2%
276,019 $12 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $20,362 - $22,371
-543 Reduced 0.21%
255,105 $10.8 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $287,524 - $327,809
-7,474 Reduced 2.84%
255,648 $11.2 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $999 - $1,212
29 Added 0.01%
263,122 $11.6 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $183,137 - $195,243
-5,553 Reduced 2.07%
263,093 $9.55 Million
Q1 2018

Apr 06, 2018

SELL
$31.91 - $37.02 $44,099 - $51,161
-1,382 Reduced 0.51%
268,646 $9.53 Million
Q4 2017

Jan 17, 2018

SELL
$33.26 - $35.29 $102,873 - $109,151
-3,093 Reduced 1.13%
270,028 $9.78 Million
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $8.47 Million - $9.33 Million
273,121
273,121 $9.75 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bar Harbor Wealth Management Portfolio

Follow Bar Harbor Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.